In a partnership with Google, Seattle-based company Lumen Bioscience can now use machine learning as a tool to expedite and streamline production of its plant-based drugs.
Earlier this year, Lumen Bioscience also received a $2M grant from the Department of Energy to support its program, “ACCESS CARBON,” which was created to support the productivity of its spirulina-based biomanufacturing.